Fortis Healthcare reports 40 percent increase in PAT to Rs 174 crore for Q1

Published On 2024-08-08 04:30 GMT   |   Update On 2024-08-08 04:30 GMT
Advertisement

Fortis Healthcare has announced a rise of 40 percent in its consolidated profit after tax (PAT), reaching Rs 174 crore for the first quarter ending June 30, 2024. This significant growth is attributed to robust performance in its hospital business. In comparison, the healthcare giant reported a PAT of Rs 124 crore for the same period last year.

Revenue from operations rose to Rs 1,859 crore in the year under review from Rs 1,657 crore in the year-ago period, Fortis Healthcare said in a BSE filing.
Advertisement
Ravi Rajagopal, Chairman, Board of Directors, Fortis Healthcare stated, “The mainstay of our performance continues to be the hospital business which presently contributes approx. 84% to our consolidated EBITDA. We are progressing well on our plans to add capacity of close to 700 beds in this fiscal year across our key facilities including Faridabad, Anandpur, Shalimar Bagh and Noida and will also be shortly commissioning the 350 bed Manesar facility
 which we acquired in FY24. In addition, given the Company’s strong Balance Sheet, we continue to evaluate inorganic growth opportunities in our key focus clusters. The diagnostics business performance is lower than the corresponding previous quarter, largely due to the impact of brand change but has witnessed signs of early improvement versus the trailing quarter. The new brand 
is being well accepted and gaining prominence; placing the business in a better position to further
 scale up its performance.”

Fortis Healthcare Limited is a integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates 28 healthcare facilities (including JVs and O&M facilities). The Company’s network comprises approximately 4,600 operational beds (including O&M beds) and ~419 diagnostics labs.

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News